STOCK TITAN
  1. Home
  2. Sec-filings
  3. IGC
  4. [EFFECT] IGC Pharma, Inc. SEC Filing

[EFFECT] IGC Pharma, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 5, 2025 4:00 P.M.
Form: S-3
CIK: 0001326205
Company Name: IGC Pharma, Inc.
File Number: 333-291567

Source: View Original Filing on SEC EDGAR

IGC Pharma Inc

NYSE:IGC

View IGC Stock Overview →

IGC Rankings

#5980 Ranked by Market Cap
N/A Ranked by Dividends

IGC Latest News

Mar 30, 2026
IGC Pharma Launches Strategic National Media Partnership with New to The Street to Expand Investor Awareness
Mar 19, 2026
IGC Pharma Reports Financial Results and Clinical Progress for the Period Ended December 31, 2025
Mar 18, 2026
IGC Pharma to Showcase AI Platform with Alzheimer's Disease Data Initiative at ADPD 2026
Feb 26, 2026
IGC Pharma Files Utility Patent Applications Covering AI-Based Data Harmonization Architecture Supporting Alzheimer's Research
Feb 24, 2026
IGC Pharma Notes Updated Research Coverage from Ascendiant Capital Markets

IGC Latest SEC Filings

Mar 30, 2026
[8-K] IGC Pharma, Inc. Reports Material Event
Mar 18, 2026
[10-KT] IGC Pharma, Inc. SEC Filing
Mar 11, 2026
[8-K] IGC Pharma, Inc. Reports Material Event
Feb 4, 2026
[Form 4] IGC Pharma, Inc. Insider Trading Activity
Jan 20, 2026
[Form 4] IGC Pharma, Inc. Insider Trading Activity

IGC Stock Data

26.81M
91.16M
Biotechnology
Pharmaceutical Preparations
Link
United States
POTOMAC